Bound 4 Blue aim to establish the ground rules, under the criteria of efficiency and energy and financial savings, for the inclusion of propulsion systems based on the use of the wind as a standard in commercial ship construction processes on a worldwide scale. Peptomyc is a start-up founded in December 2014 that develops innovative treatments for cancer based on Omomyc, the best known MYC inhibitor.
An initiative of:
Co-awarded and supported by:
